Back to Search Start Over

FADS2 and ELOVL6 mutation frequencies in Japanese Crohn's disease patients

Authors :
Mizuki Tsuruta
Kaori Matsuo
Masahiro Kojima
Mitsutaka Noguchi
Shinichiro Takami
Kan Uchiyama
Zensho Ito
Mio Sato
Shizuka Suzuki
Yutaro Motoi
Yuki Ota
Takahiro Kubota
Source :
Drug Discoveries & Therapeutics. 13:354-359
Publication Year :
2019
Publisher :
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA), 2019.

Abstract

Crohn's disease (CD) development is thought to involve genetic factors related to immune response as well as environmental factors, such as intestinal bacteria and diet, though no clear cause has yet been identified. In our previous study, we found that the concentrations of linoleic acid, stearic acid, and metabolites in erythrocytes differed between CD patients and healthy subjects. These factors related to lipid metabolism are controlled by Δ6 desaturase (fatty acid desaturase 2, FADS2) and elongase 6 (ELOVL6), respectively. In the present study, we analyzed the gene sequences of FADS2 and ELOVL6 in 52 Japanese CD patients, and then compared mutation frequencies with findings in healthy individuals. Nineteen FADS2 mutations and 33 ELOVL6 mutations were found. Furthermore, a new variant in the promoter region was shown in both genes, though no mutation in the coding region was found in either. For the FADS2 intron, the allele frequency of rs227784 (0.3365; 95% CI = 0.0337-0.01460) was higher than that in healthy subjects (0.0190). Furthermore, allele rs227784 had a greater association with CD (odds ratio = 4.4; 95% CI = 2.1-9.3). As compared with healthy Japanese healthy individuals, no mutations were found with a largely deviated allele frequency in the present CD group. However, the number of patients examined was small, thus the reliability of our results is limited. The present findings regarding genetic effects on CD onset and lipid metabolism may be weak.

Details

ISSN :
1881784X and 18817831
Volume :
13
Database :
OpenAIRE
Journal :
Drug Discoveries & Therapeutics
Accession number :
edsair.doi...........709faf366a03a5dde6fdf2f1e39bdf57
Full Text :
https://doi.org/10.5582/ddt.2019.01081